EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Functional redundancy between atypical CDKs reveals a vulnerability in hepatocellular carcinoma

Diego Martínez-Alonso, Enrique Nogueira, Luis R López-Sainz, Alexis P Pérez, Carolina Villarroya-Beltri iD, Alejandro Garcia-Diaz iD, Gloria C Bonel-Pérez iD, Aicha El Bakkali iD, Senn Wakahashi iD, Agustín Sánchez-Belmonte, Isabel García-Cao iD, Jesus Castillo-Sanchez iD und 12 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2529474123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Diego Martínez-Alonso und 23 weiteren Autor:innen. Beteiligte Einrichtung: Cell Division and Cancer group, Molecular Oncology program, Spanish National Cancer Research Center, Madrid 28029, Spain. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Cyclin-Dependent Kinases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spanish Ministry of Science, Asociacion Española contra el cancer, Asociacion Espñola contra el cáncer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The atypical cyclin-dependent kinase subfamily (CDK14–18) encompasses five related proteins with unclear function, and for which individual depletion has not demonstrated sustained therapeutic relevance. We report here that CDK16 and CDK18 compensate each other and liver cancer cells are sensitive to the concomitant inactivation of both kinases, resulting in persistent defects in DNA repair and subsequent cell death. These effects are linked to a role of CDK16/18 in regulating nucleocytoplasmatic transport through phosphorylation of nuclear pore complex components, including NUP35. Genetic ablation of Cdk16 and Cdk18 in established liver tumors driven by MYC and beta-catenin oncogenes triggers DNA damage in cancer cells without affecting adjacent normal tissue, ultimately leading to tumor regression. Collectively, these findings provide a rationale for the development of CDK16–18 inhibitors—likely targeting multiple subfamily members due to their structural similarity—as a strategy against aggressive cancers, such as hepatocellular carcinoma, where effective treatment options remain limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularCyclin-Dependent KinasesHumansAnimalsCell Line, TumorPhosphorylationDNA DamageDNA RepairNuclear Pore Complex ProteinsMice

Stichwörter der Autor:innen

DNA repairMYCcyclin-dependent kinaseshepatocellular carcinomanucleoporin

Substanzen

Cyclin-Dependent KinasesNuclear Pore Complex Proteins

Autor:innen und Institutionen

  • Cell Division and Cancer group, Molecular Oncology program, Spanish National Cancer Research Center, Madrid 28029, Spain.
  • Cancer Cell Cycle group, Systems Oncology program, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.
  • Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Confocal Microscopy Unit, Biotechnology program, Spanish National Cancer Research Center, Madrid 28029, Spain.
  • Proteomics Unit, Biotechnology program, Spanish National Cancer Research Center, Madrid 28029, Spain.

ORCID-Profile: Carolina Villarroya-Beltri, Alejandro Garcia-Diaz, Gloria C Bonel-Pérez, Aicha El Bakkali, Senn Wakahashi, Isabel García-Cao, Jesus Castillo-Sanchez, José González-Martínez, Sagrario Ortega, Fleur M Ferguson, Nathanael S Gray, Amaia Lujambio, Guillermo de Cárcer, Marcos Malumbres

Förderung

  • Spanish Ministry of Science
  • Asociacion Española contra el cancer
  • Asociacion Espñola contra el cáncer
  • Ministry of Science and Innovation Spain
  • European Union Horizon
  • MICINN-ISCIII
  • "la Caixa" Foundation
  • Comunidad de Madrid (Community of Madrid)

Zitieren

APA

Martínez-Alonso, D., Nogueira, E., López-Sainz, L. R., Pérez, A. P., Villarroya-Beltri, C., Garcia-Diaz, A., Bonel-Pérez, G. C., El Bakkali, A., Wakahashi, S., Sánchez-Belmonte, A., García-Cao, I., Castillo-Sanchez, J., González-Martínez, J., Megias, D., Sánchez, J., Geley, S., Muñoz, J., Ortega, S., Ferguson, F. M., …, & Malumbres, M. (2026). Functional redundancy between atypical CDKs reveals a vulnerability in hepatocellular carcinoma. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2529474123

Vancouver

Martínez-Alonso D, Nogueira E, López-Sainz LR, Pérez AP, Villarroya-Beltri C, Garcia-Diaz A, et al. Functional redundancy between atypical CDKs reveals a vulnerability in hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2529474123

BibTeX
@article{MartnezAlonso2026,
  author = {Martínez-Alonso, Diego and Nogueira, Enrique and López-Sainz, Luis R and Pérez, Alexis P and Villarroya-Beltri, Carolina and Garcia-Diaz, Alejandro and Bonel-Pérez, Gloria C and El Bakkali, Aicha and Wakahashi, Senn and Sánchez-Belmonte, Agustín and García-Cao, Isabel and Castillo-Sanchez, Jesus and González-Martínez, José and Megias, Diego and Sánchez, Jana and Geley, Stephan and Muñoz, Javier and Ortega, Sagrario and Ferguson, Fleur M and Gray, Nathanael S and Shields, David J and Lujambio, Amaia and de Cárcer, Guillermo and Malumbres, Marcos},
  title = {Functional redundancy between atypical CDKs reveals a vulnerability in hepatocellular carcinoma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2529474123}
}
Kostenlos starten →